Sitemap
- The Penn Vasculitis Center: A Leader in Vasculitis
- Meet the Team
- About Us
-
Research
- Active Research Studies
- Completed Research Studies
- Being a Research Participant
- Publications
-
Active Research Studies DEV
- A Randomized Multicenter Study for Isolated Skin Vasculitis (ARAMIS)
- Efficacy and Safety of Study Drug NS-229 in Treatment of Eosinophilic Granulomatosis with Polyangiitis
- Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc)
- Depemokimab Compared with Mepolizumab for Patients with EGPA on Standard of Care Therapy (OCEAN)
- Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
- Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART)
- Nasal Microbiome in ANCA Associated Vasculitis and Relapsing Polychondritis (NMB)
- Redefining Autoimmune Diseases Across Rheumatology (RADAR)
- VCRC Genetic Repository One-Time DNA Study
- VCRC Longitudinal Study of Central Nervous System Vasculitis (CNSV)
- VCRC Longitudinal Study of Eosinophilic Granulomatosis with Polyangiitis (EGPA)
- VCRC Longitudinal Study of Relapsing Polychondritis (RP)
- Vessel Wall Enhancement in Giant Cell Arteritis (VEGA)
- Patient Care
- Patient Education
- Donate